Getting paid: Brace for HA payment ‘Blues’ from a new round of private payers

Why This Topic Matters

Coverage changes for commonly used orthopedic injections can affect reimbursement, patient financial responsibility, and office workflow. The article is useful for practices tracking payer policy updates, precertification requirements, and Medicare’s current evaluation of the therapy.

Article Sections

1. Private payer coverage changes

   This section summarizes recent policy updates from multiple commercial payers and the timing of expected coverage changes. It places those updates in the context of broader shifts in insurer treatment of this therapy.

2. Affected products and billing impact

   This section discusses the products and claims implications for practices, including patient notification and administrative handling. It also notes how some payers may continue coverage under precertification requirements.

3. Aetna precertification and medical policy

   This section describes Aetna’s updated administrative requirements and the related clinical policy context. It focuses on how the payer is positioning the therapy within its medical necessity framework.

4. Medicare is studying the matter for now

   This section covers Medicare’s current coverage status and the related evidence review process. It summarizes the role of outside assessment organizations and the scope of the ongoing evaluation.